Skip to content

Mental Health in Austrian Teenagers (MHAT)

The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03301077
Acronym
MHAT
Enrollment
4000
Registered
2017-10-04
Start date
2013-01-31
Completion date
2015-04-30
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Keywords

children and adolescents, mental health, epidemiology, psychiatric disorders

Brief summary

The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Detailed description

Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents. The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5): 1. Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life. 2. Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Interventions

OTHER2-phase epidemiological study (screening, interviews)

first phase is the screening phase, second phase is the interview phase

Sponsors

Ludwig Boltzmann Institute Health Promotion Research
CollaboratorUNKNOWN
Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag
CollaboratorOTHER
Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* adolescents aged 10-18

Exclusion criteria

* no written informed consent possible due to intelligence or no willingness by parents to include minor

Design outcomes

Primary

MeasureTime frameDescription
psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)12 monthsScreening and interview

Secondary

MeasureTime frameDescription
rates of behavioral, emotional and social problems (representation of data collected at interview)12 monthsYSR (Youth Self Report) questionnaire
psychiatric disorder related risks and protective factors (representation of data collected at interviews)12 monthsKinder-DIPS (Diagnostisches Interview psychischer Störungen) interview
quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)12 monthsKIDSCREEN (Kidscreen) questionnaire

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026